Anzeige
Mehr »
Samstag, 16.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LA7D | ISIN: CA65337X1042 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXGENRX INC Chart 1 Jahr
5-Tage-Chart
NEXGENRX INC 5-Tage-Chart

Aktuelle News zur NEXGENRX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrNexgenRx declares CAD 0.005 dividend1
FrNexgenRx Inc.: NexgenRx Announces Declaration of Dividend231TORONTO, ON / ACCESS Newswire / August 15, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been...
► Artikel lesen
MiNexgenrx reports Q2 results1
MiNexgenRx Inc: NexgenRx's Q2 2025 revenue at $349,0431
MiNexgenRx Inc.: NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA316TORONTO, ON / ACCESS Newswire / August 12, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2025, with quarterly...
► Artikel lesen
15.05.NexgenRx, Inc.: NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA285TORONTO, ON / ACCESS Newswire / May 15, 2025 / NEXGENRX INC. (TSX.V:NXG) ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2025, with quarterly...
► Artikel lesen
18.04.NexgenRx declares CAD 0.005 dividend1
NEXGENRX Aktie jetzt für 0€ handeln
18.04.NexgenRx Inc: NexgenRx to pay 0.5-cent dividend April 301
17.04.NexgenRx Inc.: NexgenRx Announces Declaration of Divdend340TORONTO, ON / ACCESS Newswire / April 17, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been...
► Artikel lesen
04.04.Nexgenrx reports FY results1
04.04.NexgenRx, Inc.: NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA428TORONTO, ON / ACCESS Newswire / April 3, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2024, with continued...
► Artikel lesen
26.11.24NexgenRx Inc.: NexgenRx Announces Third Quarter Results and Declaration of Divdend366TORONTO, ON / ACCESSWIRE / November 25, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the third quarter ended September 30, 2024, with quarterly...
► Artikel lesen
07.10.24NexgenRx, Inc.: NexgenRX Announces Director Re-Appointment405TORONTO, ON / ACCESSWIRE / October 7, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the re-appointment of Charles Burns to its Board of Directors effective immediately. Mr....
► Artikel lesen
01.10.24NexgenRx Inc.: NexgenRx Announces New Director213TORONTO, ON / ACCESSWIRE / October 1, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the appointment of Linda Brennan to its Board of Directors effective immediately.Linda...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1